drugset / Trial / NCT07635394
Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
Recruiting
258 enrolled
Beijing Tiantan Hospital
Beijing Jianjia Rehabilitation Hospital · collabHebei Medical University Third Hospital · collabHengshui People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).
Timeline
- Start
- 2026-04-07
- Primary completion
- 2026-04-08
- Completion
- 2029-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 225 mg | — |
| Background | Dicyclomine | Small molecule | — | — |
| Background | Eluxadoline | Small molecule | 75 mg | — |
| Background | Eluxadoline | Small molecule | 100 mg | — |
| Background | Hyoscyamine | Small molecule | — | — |
| Background | Loperamide | Small molecule | — | — |
| Background | Rifaximin | Other / unclassified | 550 mg | — |